PremiumCompany AnnouncementsDBS reshapes North Asia and Indonesia leadership with internal promotions23h ago
PremiumRatingsAnalyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers24h agoTAK
Analyst Raises Price Target to ¥6,800 and Reiterates Buy on Strong Drug Performance, Pipeline Upside, and Long-Term Growth Drivers
PremiumCompany AnnouncementsOCBC Prices S$750 Million Perpetual AT1 Capital Securities for SGX Listing1d ago
PremiumCompany AnnouncementsTotalEnergies Updates Share Capital and Voting Rights as of July 31, 20262d agoTTE
PremiumCompany AnnouncementsEni Expands Treasury Stock Through Ongoing €1.19 Billion Share Buyback2d ago